Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marta Masztalewicz has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oral Microbiota in Atherosclerosis and Ischemic Stroke: A Compartment-Resolved Critical Narrative Review of Immunoinflammatory Mechanisms and Clinical Evidence

    by Nikodem Miłoszewski, Ewa Ostrycharz-Jasek, Agnieszka Meller, Paulina Warias, Karolina Machowska-Sempruch, Tomas Simurda, Jan Mikler, Marta Masztalewicz, Wioletta Pawlukowska

    Periodontitis and oral microbial signals have been associated with atherosclerosis and ischemic stroke, but findings from oral samples, carotid plaques, cerebral thrombi, and clinical studies support different inferences. We conducted a critical narrative synthesis of 180 full-text publications identified through a structured search of PubMed/MEDLINE, Web of Science, and Scopus. Building on the existing stroke-focused narrative review and the 2024–2026 meta-analytic literature, this review provides a compartment-resolved critical appraisal of the evidence needed to link an oral microbial source to a specific vascular lesion, ischemic stroke mechanism, and clinically meaningful outcome. A cross-study comparison of carotid plaque and cerebral thrombus findings anchors five interpretive checkpoints: oral-source attribution, systemic exposure, vascular-compartment localization, local biological activity, and clinical-event modification. Observational studies suggest a modest association between periodontitis and stroke, but heterogeneity and residual confounding limit causal inference. Detection of microbial DNA or proteins in vascular specimens does not establish oral origin, viability, or pathogenic activity. Periodontal interventions improve selected inflammatory and vascular surrogate outcomes, but evidence of fewer first or recurrent strokes remains inconclusive. The proposed framework guides appraisal and study design; it is not a validated causal model or diagnostic tool. Established periodontal care and structured post-stroke oral hygiene remain warranted, whereas microbiome-guided prediction and periodontal treatment specifically for stroke prevention remain investigational.

  • Open Access

    Polish Adaptation and Initial Psychometric Evaluation of the Hungarian Aphasia Screening Test (HAST-PL)

    by Wioletta Pawlukowska, Krzysztof Wietrzyński, Agnieszka Wasilczyk-Kryger, Tatiana Lewicka, Ewa Maciorowska, Karolina Sempruch-Machowska, Danuta Wojtas-Kłucińska, Weronika Żmuda, Lilla Zakariás, Marta Masztalewicz, et al.

    Background/Objectives: This study developed a Polish adaptation of the Hungarian Aphasia Screening Test (HAST-PL) and evaluated its internal structure, internal consistency, and screening accuracy. Methods: Following translation and expert-led adaptation, 173 stroke survivors (130 with clinically confirmed aphasia and 43 without aphasia) were analysed. Clinical status was established before HAST-PL through neurological and speech-language assessment supplemented by medical records. Analyses included ordinal confirmatory factor analysis (CFA), internal consistency, group comparisons, ROC analysis, and 20,000 stratified bootstrap resamples with repeated cut-off selection. CFA was also performed in the aphasia group. Results: The one-factor model yielded CFI = 0.991, TLI = 0.981, RMSEA = 0.086, and SRMR = 0.051; the aphasia-only analysis showed a similar pattern. Internal consistency was acceptable (α = 0.805; ω = 0.834). All five tasks differentiated the groups (p ≤ 0.028). AUC was 0.88 (95% CI [0.83, 0.93]). Screen-positive scores ≤16 yielded 66.2% sensitivity and 97.7% specificity; ≤17 yielded 77.7% and 86.0%, respectively. The apparent maximum Youden index of 0.6383 decreased to 0.6141 after bootstrap correction. The ≤16 and ≤17 rules were selected in 51.265% and 47.950% of resamples, respectively. Conclusions: HAST-PL shows initial promise for aphasia screening. Internal validation supports evaluating both neighbouring thresholds rather than adopting either as a definitive clinical rule. Negative results cannot exclude clinically suspected aphasia, and independent external validation remains necessary.

  • Open Access

    The Association Between the Occurrence of Sensory Integration Disorders, Depression, and Chronic Fatigue in Patients with Relapsing–Remitting Multiple Sclerosis

    by Karolina Machowska-Sempruch, Marta Masztalewicz, Agnieszka Meller, Przemysław Nowacki, Wioletta Pawlukowska

    Background/Objectives: Multiple sclerosis (MS) is a chronic neurological disease associated not only with motor dysfunction but also with non-motor symptoms such as depression and MS-related fatigue (MSRF). Sensory integration disorders (SID) in MS remain poorly characterized. This study aimed to evaluate the association between SID and depression, MSRF, disability level, disease duration, and disease activity in patients with relapsing–remitting MS (RRMS). Methods: A total of 205 patients with RRMS were assessed using the Daniel Travis sensory integration questionnaire, Beck Depression Inventory (BDI), EDSS, FSMC fatigue scale, and MRI T2-lesion burden. Due to non-normal distribution, non-parametric statistical tests were applied with significance set at p < 0.05. Results: Statistically significant associations were identified between SID and depressive symptoms. Compared with patients without depression, individuals with mild to severe depression showed significantly higher impairment in under-responsiveness/sensory seeking (p = 0.040), sensory discrimination (p = 0.017 for mild; p = 0.011 for severe), sensory-based motor abilities (p = 0.007 for severe), and social–emotional functioning (p = 0.006 for mild; p = 0.014 for severe). Higher disability (EDSS > 3) was associated with impaired sensory discrimination (p = 0.013) and reduced motor abilities (p = 0.000). Longer disease duration was linked to poorer general sensory modulation (≤5 vs. 5–10 years p = 0.038; ≤5 vs. >10 years p = 0.037) and reduced motor abilities (>10 years p = 0.042). Increased disease activity (1 or ≥2 relapses/year) correlated with more severe under-responsiveness/sensory seeking (p = 0.039) and worse social–emotional functioning (p = 0.025 and p = 0.007). No significant association was found between SID and MSRF or MRI T2-lesion count. Conclusions: In conclusion, sensory integration disorders in RRMS are strongly associated with depression, disability level, disease duration, and relapse rate, but not with MSRF. SID assessment may provide additional insight into non-motor symptom burden and disease progression.

  • Open Access

    The Association Between the Occurence of Sensory Integration Disorders, Depression, and Chronic Fatigue Syndrome in Patients with Relapsing-Remitting Multiple Sclerosis

    by Karolina Machowska-Sempruch, Marta Masztalewicz, Agnieszka Meller, Przemysław Nowacki, Wioletta Pawlukowska

    Background: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system associated with both motor and non-motor symptoms. Depression and chronic fatigue syndrome (CFS) are frequent in relapsing–remitting MS (RRMS), but the role of sensory integration disorders (SID) remains unclear. Methods: This cross-sectional study included 205 RRMS patients (147 females, 58 males; aged 19–69 years) treated at the Pomeranian Medical University, Szczecin (2022–2023). SID were evaluated using the Daniel Travis Questionnaire, depression using the Beck Depression Inventory (BDI), fatigue using the Fatigue Scale for Motor and Cognitive Functions (FSMC), and disability using the Expanded Disability Status Scale (EDSS). MRI T2 lesion counts and relapse rates were analyzed using non-parametric tests (p < 0.05). Results: SID were significantly associated with depression severity. Patients with moderate to severe depression showed greater impairment in sensory discrimination, motor abilities, and emotional functioning (p < 0.05). Higher disability (EDSS > 3) and longer disease duration correlated with worse SID scores. Relapse frequency was linked to poorer sensory-seeking and emotional domains, while no association was found between SID and CFS or MRI lesion load. Conclusions: SID are prevalent in RRMS and correlate with depression, disease duration, and disability, suggesting potential therapeutic value in sensory-based rehabilitation.

  • Open Access

    Oral Health in Patients Hospitalized Because of Ischemic Stroke

    by Anna Dziewulska, Wioletta Pawlukowska, Alicja Zawiślak, Marta Masztalewicz, Katarzyna Grocholewicz

    Background/Objectives: Maintenance of good oral health is relevant to overall health and quality of life. Results of many analyses showed that stroke patients had worse oral health than the control population. The aim of this study was a clinical assessment of oral condition in post-stroke patients and a healthy population. Methods: Oral health was assessed in stroke patients on the first day of ischemic stroke, and in a control group of healthy subjects. The number of teeth, the presence of active carious foci, fillings, and prosthetic restorations were evaluated. To assess oral hygiene, the Approximal Plaque Index (API) was used. In periodontal examinations, the presence of dental deposits, the depth of the existing periodontal pockets, tooth mobility, and the Sulcus Bleeding Index (SBI) during probing were assessed. Results: Significantly higher mean values of Decayed Teeth (DT), Missing Teeth (MT), and Decayed, Missing, and Filled Teeth (DMFT) indices were recorded in the study group. The incidence of dental caries, API, and SBI was also significantly higher in the study group. The study and control groups did not differ significantly in the average number of pockets 3 mm deep and deeper and in the frequency of having prosthetic restorations. Conclusions: Oral health and the level of oral hygiene in patients hospitalized because of ischemic stroke, in comparison with that in a healthy population, is not satisfactory. Active interdisciplinary collaboration between various medical specialists in the therapy of patients with general illnesses, including stroke, is strongly recommended.


  • Open Access

    Profile of Sensory Integration Disorders in Migraine Patients—New Perspectives of Therapy

    by Agata Kaniewska, Ewelina Bagińska, Marta Masztalewicz, Krystian Mross, Marta Jankowska, Przemysław Nowacki, Agnieszka Meller, Karolina Machowska-Sempruch, Wioletta Pawlukowska

    Background: The involvement of sensory integration disorders in the pathophysiology of migraine has been suggested. This study aims to analyze the relationship between symptoms of sensory integration disorders and migraine in a broad scope, including all sensory domains, and examine its impact on migraine attacks. Methods: The study included 372 people diagnosed with migraine. The Daniel Travis Questionnaire was used to assess symptoms of sensory integration disorders and their severity across six domains. The relationships between the severity of these symptoms and headache features, as well as accompanying headache symptoms, were the subject of statistical analysis. Results: Current impairment in all sensory domains was significantly associated with headaches exacerbated by everyday life activities. A significant inverse relationship was found between the occurrence of throbbing headaches and symptoms of sensory integration disorders in terms of current sensory discrimination, current motor skills, and current emotional/social skills. Past under-responsiveness and past disturbances in emotional/social abilities were significantly associated with migraine aura. Conclusions: The severity of symptoms of sensory integration disorders affects the clinical picture of migraine. The significant association between migraine and emotional/social disorders, as well as under-responsiveness in the past, needs further research to assess whether this is a cause-and-effect relationship. There is a need for in-depth diagnostics of sensory integration disorders in migraine patients, which could be an additional target of their therapy.


  • Open Access

    Statins and 90-Day Functional Performance and Survival in Patients with Spontaneous Intracerebral Hemorrhage

    by Karolina Zaryczańska, Wioletta Pawlukowska, Przemysław Nowacki, Łukasz Zwarzany, Ewelina Bagińska, Monika Kot, Marta Masztalewicz

    Background: The neuroprotective effect of statins has become a focus of interest in spontaneous intracerebral hemorrhage (sICH). The purpose of this study was: (1) to evaluate the effect of statin use by the analyzed patients with sICH in the period preceding the onset of hemorrhage on their baseline neurological status and baseline neuroimaging of the head; (2) to evaluate the effect of statin use in the acute period of hemorrhage on the course and prognosis in the in-hospital period, taking into account whether the statin was taken before the hemorrhage or only after its onset; (3) to evaluate the effect of continuing statin treatment after in-hospital treatment on the functional performance and survival of patients up to 90 days after the onset of sICH symptoms, taking into account whether the statin was taken before the onset of sICH. Material and Methods: A total of 153 patients diagnosed with sICH were analyzed, where group I were not previously taking a statin and group II were taking a statin before sICH onset. After lipidogram assessment, group I was divided into patients without dyslipidemia and without statin treatment (Ia) and patients with dyslipidemia who received de novo statin treatment during hospitalization (Ib). Group II patients continued taking statin therapy. We evaluated the effect of prior statin use on the severity of hemorrhage; the effect of statin use during the acute period of sICH on its in-hospital course; and the effect of statin treatment on the severity of neurological deficit, functional capacity and survival of patients up to 90 days after the onset of sICH symptoms. Results: There was no effect of prior statin use on the severity of hemorrhage as assessed clinically and by neuroimaging of the head. At in-hospital follow-up, subgroup Ia was the least favorable in terms of National Institutes of Health Stroke Scale (NIHSS) score. This subgroup had the highest percentage of deaths during hospitalization. In the post-hospital period, the greatest number of patients with improvement in the NIHSS, modified Rankin Scale (mRS) and Barthel scales were among those taking statins, especially group II patients. At 90-day follow-up, survival analysis fell significantly in favor of subgroup Ib and group II. Conclusions: 1. The use of statins in the pre-sICH period did not adversely affect the patients’ baseline neurological status or the results of baseline neuroimaging studies. 2. Continued statin therapy prior to the onset of sICH or the inclusion of statins in acute treatment in patients with sICH and dyslipidemia does not worsen the course of the disease and the in-hospital prognosis. Statin therapy should not be discontinued during the acute phase of sICH. 3. To conclude the eventual beneficial effect on the functional performance and survival of patients after sICH onset, comparability of the analyzed groups in terms of clinical, radiological and other prognostic factors in spontaneous intracerebral hemorrhage would be needed. Future studies are needed to confirm these findings.


  • Open Access

    Microglia and Astroglia—The Potential Role in Neuroinflammation Induced by Pre- and Neonatal Exposure to Lead (Pb)

    by Magdalena Gąssowska-Dobrowolska, Mikołaj Chlubek, Agnieszka Kolasa, Patrycja Tomasiak, Jan Korbecki, Katarzyna Skowrońska, Maciej Tarnowski, Marta Masztalewicz, Irena Baranowska-Bosiacka

    Neuroinflammation is one of the postulated mechanisms for Pb neurotoxicity. However, the exact molecular mechanisms responsible for its pro-inflammatory effect are not fully elucidated. In this study, we examined the role of glial cells in neuroinflammation induced by Pb exposure. We investigated how microglia, a type of glial cell, responded to the changes caused by perinatal exposure to Pb by measuring the expression of Iba1 at the mRNA and protein levels. To assess the state of microglia, we analyzed the mRNA levels of specific markers associated with the cytotoxic M1 phenotype (Il1b, Il6, and Tnfa) and the cytoprotective M2 phenotype (Arg1, Chi3l1, Mrc1, Fcgr1a, Sphk1, and Tgfb1). Additionally, we measured the concentration of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α). To assess the reactivity and functionality status of astrocytes, we analyzed the GFAP (mRNA expression and protein concentration) as well as glutamine synthase (GS) protein level and activity. Using an electron microscope, we assessed ultrastructural abnormalities in the examined brain structures (forebrain cortex, cerebellum, and hippocampus). In addition, we measured the mRNA levels of Cxcl1 and Cxcl2, and their receptor, Cxcr2. Our data showed that perinatal exposure to Pb at low doses affected both microglia and astrocyte cells’ status (their mobilization, activation, function, and changes in gene expression profile) in a brain-structure-specific manner. The results suggest that both microglia and astrocytes represent a potential target for Pb neurotoxicity, thus being key mediators of neuroinflammation and further neuropathology evoked by Pb poisoning during perinatal brain development.


  • Open Access

    Application of Original Therapy for Stimulation of Oral Areas Innervated by the Trigeminal Nerve in a Child with Beckwith–Wiedemann Syndrome

    by Wioletta Pawlukowska, Michał Patalan, Ewelina Bagińska, Maria Giżewska, Marta Masztalewicz

    About 90% of children diagnosed with classic BWS have macroglossia, and 40% of them are submitted to surgical tongue reduction. The purpose of our article is to present a case study of a 5-month-old child with BWS who was treated with an original therapy for stimulation of oral areas innervated by the trigeminal nerve. The therapy included stimulation of the upper and lower lip and muscles of the floor of the mouth. The treatment was provided by a therapist once a week. In addition, the child was stimulated every day at home by his mother. After 3 months, a significant improvement in oral alignment and function was achieved. Preliminary observations of therapy application for stimulation regions innervated by the trigeminal nerve in children with Beckwith–Wiedemann syndrome seem promising. The original therapy for stimulation of oral areas innervated by the trigeminal nerve is a good alternative to existing methods of surgical tongue reduction in children with BWS and macroglossia.

  • Open Access

    Acute Tongue Swelling as a Still Unexpected Manifestation of Internal Carotid Artery Dissection: A Case Report

    by Wioletta Pawlukowska, Krystian Mross, Marta Jankowska, Łukasz Zwarzany, Wojciech Poncyljusz, Marta Masztalewicz

    The diagnosis of internal carotid artery dissection (ICAD) at the stage of local signs is essential in the prevention of the life-treating cerebral complication; however, making this diagnosis has significant difficulties. We present the case of a 36-year-old female with left ICAD with asymmetric left-sided tongue swelling as an unusual and still unexpected symptom. The patient’s complaints at admission were left-sided numbness of the tongue and swallowing difficulties but its movements were intact. Despite the provided treatment for suspected angioedema, no improvement was noted. Additional examination revealed left-sided tongue weakness, ipsilateral soft palate palsy, paralysis and reduced tension of the left vocal fold, and left-sided Horner’s syndrome. Another suspected diagnosis was a dysfunction of the IX, X, and XII cranial nerves. A head MRI revealed an intramural hematoma of the left internal carotid artery. The radiologists suggested ICAD. The angio-MRI of the head arteries confirmed this diagnosis. The patient received dual antiplatelet therapy. The neuro-logopaedic therapy was also implemented. Currently, the patient’s symptoms are gradually improving with significantly better results on follow-up neuroimaging. Among the possible local symptoms of ICAD, proper attention should be paid to asymmetric swelling of the tongue as an atypical manifestation of damage to the hypoglossal nerve.